Live in-person:

30 Jan - 2 Feb 2023

Dubai World Trade Centre


4 Jan - 2 Mar 2023

Unlocking the power of precision medicine for population genome programs​


G42 Healthcare


Tuesday 31st January | 10:30

Transformation Zone | P.L10




Learn about how G42 Healthcare is running the region’s largest and most comprehensive population genomics program. In addition, discover how insights from population-wide genomics program will impact growth in precision medicine. 

Company bio

G42 Healthcare, a leading AI-powered healthcare company, is on a mission to develop a world-class healthcare sector in the UAE and beyond, by harnessing data and emerging technologies in healthcare to unlock the potential of personalized and preventive care.Agile and futuristic, we have created a transformative shift in the traditional healthcare paradigm.

As a visionary health tech company, we partner with governments, leading international entities, scientists and researchers and the wider medical community who subscribe to our values and our mission as we develop solutions to future-proof the health of nations. We have built Biogenix Labs, UAE’s first COVID-19 accredited large-scale throughput laboratory, and facilitated the 4Humanity clinical trials, the world’s first phase three trial for inactivated vaccine against COVID-19 with over 43,000 volunteers from 125+ nationalities across the pan-Arab region.

From harnessing big data and cloud computing to building the largest biobank in the world, from clinical trials and drug research to delivering healthcare industry solutions that address near- and long-term opportunities, our robust pipeline of offerings across the entire healthcare value chain will transform the future of healthcare.



Dr Patrick Merel
Director of Genomics
G42 Healthcare

Dr Patrick Merel got his PhD in Molecular Biology from University of Bordeaux, France. With 20 years of academic experience, he has been building and running molecular diagnostic, genetic and genomic clinical settings as well a translational research platform through several directorships while at Bordeaux Blood Bank Center, then at University Hospital of Bordeaux, from 1987 to 2012.

Dr Patrick has built a strong experience in the industry as well, moving to San Diego, CA, in 2004-2005, to be in residence consultant for Beckman Coulter Inc. executive team, helping the CEO to move the company into the molecular IVD business and participating to major M&A projects.

Dr Patrick has moved back to the USA in 2012, to become entrepreneur and start 2 companies in San Diego, Portable Genomics, Inc. a genomics and digital health company, and Edico Genome, a bioinformatics hardware company, who developed the Dragen, sold to Illumina in 2018. Dr Patrick Merel, is now the Director of Genomics at G42 Healthcare, in Abu Dhabi, UAE.